These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 26232222)

  • 1. Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.
    Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium
    Cell; 2015 Jul; 162(3):516-26. PubMed ID: 26232222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modifier of Huntington's disease onset at the MLH1 locus.
    Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
    Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
    Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
    Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-specific genetic modification of Huntington's disease in Venezuela.
    Chao MJ; Kim KH; Shin JW; Lucente D; Wheeler VC; Li H; Roach JC; Hood L; Wexler NS; Jardim LB; Holmans P; Jones L; Orth M; Kwak S; MacDonald ME; Gusella JF; Lee JM
    PLoS Genet; 2018 May; 14(5):e1007274. PubMed ID: 29750799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.
    Pinto RM; Dragileva E; Kirby A; Lloret A; Lopez E; St Claire J; Panigrahi GB; Hou C; Holloway K; Gillis T; Guide JR; Cohen PE; Li GM; Pearson CE; Daly MJ; Wheeler VC
    PLoS Genet; 2013 Oct; 9(10):e1003930. PubMed ID: 24204323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Soliveri P; Lange HW; Weirich-Schwaiger H; Wenning GK; Melegh B; Havasi V; Balikó L; Wieczorek S; Arning L; Zaremba J; Sulek A; Hoffman-Zacharska D; Basak AN; Ersoy N; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Neurogenetics; 2006 Mar; 7(1):27-30. PubMed ID: 16369839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.
    Holmans PA; Massey TH; Jones L
    Hum Mol Genet; 2017 Oct; 26(R2):R83-R90. PubMed ID: 28977442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modifiers of Huntington's disease.
    Gusella JF; MacDonald ME; Lee JM
    Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's Disease.
    Hong EP; Chao MJ; Massey T; McAllister B; Lobanov S; Jones L; Holmans P; Kwak S; Orth M; Ciosi M; Monckton DG; Long JD; Lucente D; Wheeler VC; MacDonald ME; Gusella JF; Lee JM
    J Huntingtons Dis; 2021; 10(3):367-375. PubMed ID: 34180418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Mariotti C; Lange HW; Weirich-Schwaiger H; Wenning GK; Seppi K; Melegh B; Havasi V; Balikó L; Wieczorek S; Zaremba J; Hoffman-Zacharska D; Sulek A; Basak AN; Soydan E; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Hum Genet; 2006 Sep; 120(2):285-92. PubMed ID: 16847693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
    Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
    Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease.
    Metzger S; Rong J; Nguyen HP; Cape A; Tomiuk J; Soehn AS; Propping P; Freudenberg-Hua Y; Freudenberg J; Tong L; Li SH; Li XJ; Riess O
    Hum Mol Genet; 2008 Apr; 17(8):1137-46. PubMed ID: 18192679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase.
    Long JD; Lee JM; Aylward EH; Gillis T; Mysore JS; Abu Elneel K; Chao MJ; Paulsen JS; MacDonald ME; Gusella JF
    Am J Hum Genet; 2018 Sep; 103(3):349-357. PubMed ID: 30122542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome substitution strain assessment of a Huntington's disease modifier locus.
    Ramos EM; Kovalenko M; Guide JR; St Claire J; Gillis T; Mysore JS; Sequeiros J; Wheeler VC; Alonso I; MacDonald ME
    Mamm Genome; 2015 Apr; 26(3-4):119-30. PubMed ID: 25645993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
    Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
    J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.